Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

8.4K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.4K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

19.2K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
19.2K
RNA Interference01:23

RNA Interference

29.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
29.0K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

3.4K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
3.4K
CRISPR01:59

CRISPR

60.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
60.5K
Types of RNA01:20

Types of RNA

16.8K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
16.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating <i>Malat1</i>-derived 3'end sequences for functional transgene expression in human cells using synthetic mRNA delivery.

RNA biology·2026
Same author

RNA-seq-derived sequence variations are excellent features for cell line identification.

Computational and structural biotechnology journal·2026
Same author

FOXM1 regulates platelet-induced anoikis resistance in pancreatic cancer cells.

Cell communication and signaling : CCS·2026
Same author

Two-color spheroid model for determining the O<sub>2</sub>-induced radiosensitivity of HNSCC.

Journal of biological engineering·2026
Same author

Functional and Biological Characterization of the LGR5Δ5 Splice Variant in HEK293T Cells.

International journal of molecular sciences·2025
Same author

Expression profiling of primary and metastatic oral squamous cell carcinoma identifies progression-associated transcriptome changes and therapeutic vulnerabilities.

Cancer communications (London, England)·2025

Related Experiment Video

Updated: Apr 20, 2026

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery
07:49

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

Published on: May 30, 2025

2.9K

Silencing long noncoding RNAs with genome-editing tools.

Tony Gutschner1

  • 1Department of Genomic Medicine, The University of Texas M.D. Anderson Cancer Center, 1901 East Road, Houston, TX, 77054, USA, tgutschner@mdanderson.org.

Methods in Molecular Biology (Clifton, N.J.)
|November 20, 2014
PubMed
Summary

Researchers developed a new method to target long noncoding RNAs (lncRNAs) in cancer cells. This approach uses Zinc Finger Nucleases (ZFNs) to specifically reduce the expression of MALAT1, a key lncRNA in lung cancer.

More Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.3K
In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

2.2K

Related Experiment Videos

Last Updated: Apr 20, 2026

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery
07:49

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

Published on: May 30, 2025

2.9K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.3K
In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

2.2K

Area of Science:

  • Molecular Biology
  • Genomics
  • Cancer Research

Background:

  • Long noncoding RNAs (lncRNAs) are a vast and diverse class of transcripts in the human transcriptome.
  • Despite their abundance, the functional analysis of lncRNAs is lagging due to a lack of efficient loss-of-function methods.
  • Targeting highly abundant lncRNAs like MALAT1 in cancer cells presents a significant challenge.

Purpose of the Study:

  • To develop a specific and efficient method for reducing the expression of the lncRNA MALAT1 in human lung cancer cells.
  • To overcome the limitations of current loss-of-function approaches for lncRNA analysis.
  • To enable detailed functional studies of abundant lncRNAs in disease contexts.

Main Methods:

  • Utilizing Zinc Finger Nucleases (ZFNs) for targeted genomic integration.
  • Engineering site-specific integration of RNA-destabilizing elements.
  • Applying the method to human lung cancer cell lines to target MALAT1 expression.

Main Results:

  • Demonstrated a method for specific and efficient targeting of the MALAT1 lncRNA.
  • Successfully reduced the expression of MALAT1 in human lung cancer cells.
  • Established a viable loss-of-function approach for studying abundant lncRNAs.

Conclusions:

  • The described ZFN-mediated method provides an effective tool for the functional analysis of lncRNAs.
  • This approach facilitates the study of MALAT1 and potentially other abundant lncRNAs in cancer.
  • Enabling loss-of-function studies will accelerate our understanding of lncRNA roles in human diseases.